Empire Life Investments’s Accenture ACN Stock Holding History

Empire Life Investments’s Portfolio ACN Stock Details ACN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-92,761	Closed	-$24.9M	–	111
2025 Q4	$24.9M	Buy	+92,761	New	+$23.6M	1.4%	24

Other funds holding ACN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Empire Life Investments's ACN Position: Q1 2026 in Review

Empire Life Investments sold out of Accenture (ACN) in Q1 2026, closing a stake of 92,761 shares — an estimated $24.9M sold.

Empire Life Investments first reported a position in ACN in Q4 2025 and held it in 1 quarter. The position peaked at $24.9M in Q4 2025. 2,150 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

Empire Life Investments reported no remaining Accenture position as of Q1 2026 after selling out during the quarter.
Empire Life Investments sold 92,761 Accenture shares in Q1 2026, an estimated $24.9M.
Empire Life Investments first reported a position in Accenture in Q4 2025 and held it in 1 quarter.
Empire Life Investments's Accenture position peaked at $24.9M in Q4 2025.
2,150 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Empire Life Investments's 13F filing for Q1 2026, filed 11 May 2026.